Records containing: Unspecified Adult Solid Tumor, Protocol Specific
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-11-06A Phase I Trial of Bizelesin (NSC 615291) Using a Single Bolus Infusion Given Every Twenty-eight (28) Days in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2012-10-17Phase II Trial Of Subcutaneous Amifostine For Reversal Of Persistent Paclitaxel-Induced Peripheral Neuropathy
-
CLINICAL_TRIALS study record update · 2012-10-04Assessment of Early and Standard Intervention With Procrit® (Epoetin Alfa) 120,000 Units Once Every Three Weeks (Q3W) in Patients With Cancer Receiving Chemotherapy
-
CLINICAL_TRIALS study record update · 2012-10-04Phase I Study Of BMS-599626 In Patients With Advanced Solid Malignancies That Express Her2
-
CLINICAL_TRIALS study record update · 2012-10-04A Study to Assess HER2-Specific T Cell Responses in Patients Receiving Trastuzumab for Solid Tumor Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-09-26Phase I Study of Combination Therapy With Oral 9-Nitrocamptothecin and Oral Etoposide
-
CLINICAL_TRIALS study record update · 2012-09-24Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam
-
CLINICAL_TRIALS study record update · 2012-09-24Oral Empirical Therapy of Fever in Low-Risk Neutropenic Cancer Patients: A Prospective, Double-Blind, Randomized, Multicenter Trial Comparing Monotherapy (Single Daily Dose Moxifloxacin) With Combination Therapy (Ciprofloxacin Plus Amoxicillin/Clavulanic Acid)
-
CLINICAL_TRIALS study record update · 2012-09-24Phase I Study to Determine the Safety of MS-209 in Combination With Docetaxel in Patients With a Solid Progressive Tumor
-
CLINICAL_TRIALS study record update · 2012-09-24Phase I Trial of NGR-TNF Administered Every 3 Weeks as a 1 Hour Intravenous Infusion in Patients With Solid Tumor
-
CLINICAL_TRIALS study record update · 2012-09-18A Phase II Study of Hypofractionated Highly Conformal Radiation With Helical Tomotherapy for Extra-Cranial Oligo
-
CLINICAL_TRIALS study record update · 2012-09-06Phase III Randomized Trial of an Opioid Titration Order Sheet Compared to Standard of Care in Patients With Cancer Related Pain.
-
CLINICAL_TRIALS study record update · 2012-08-31Phase I Study of Continuous Weekly Dosing of Dimethyl Benzoylphenylurea (BPU) in Patients With Solid Tumors Not Responding to Conventional Therapy
-
CLINICAL_TRIALS study record update · 2012-08-28A Phase I, Open-Label Study to Determine the Maximum Tolerated Dose (MTD) and to Evaluate the Safety Profile of CC-4047 in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-08-27An International Field-Testing Study Of The Reliability And Validity Of A Patient Satisfaction Module (QLQ-SAT32) Assessing Cancer Patients' Perception Of The Quality Of Care Received Within The Hospital
-
CLINICAL_TRIALS study record update · 2012-08-14Phase II Study of Metastatic Cancer That Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes and Dendritic Cell Vaccination
-
CLINICAL_TRIALS study record update · 2012-08-09Phase I and Pharmacokinetic Study of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-08-09A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous CCI-779 Given Once Daily for 5 Days Every 2 Weeks to Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-08-09Phase I and Pharmacokinetic Study of FB-642 Administered Orally on a Weekly Schedule to Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-08-09A Phase I Study of Cyclic Oral Administration of SCH 52365 for 21 of 28 Days in Patients With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2012-07-24Phase I Clinical Trial of Recombinant Viscumin (rViscumin, rMistletoe Lectin, rML) Administered Twice Weekly By The Intravenous Route In Patients With Solid Tumors After Failure of Standard Therapy
-
CLINICAL_TRIALS study record update · 2012-07-24Phase I Study To Determine The Safety Of Halofuginone In Patients With A Solid Progressive Tumor
-
CLINICAL_TRIALS study record update · 2012-07-18Phase I Clinical Trial of Recombinant Viscumin (rVISCUMIN, rMISTLETOE LECTIN, rML) Administered Twice Weekly by the Subcutanous Route in Patients With Solid Tumors After Failure of Standard Therapy
-
CLINICAL_TRIALS study record update · 2012-07-18A Phase I, Open Label Multiple Dose, Safety and Pharmacokinetic Study of Intravenously Administered Humanized Anti-VEGF Monoclonal Antibody (HuMV833) to Patients With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-07-11Phase I Study to Determine the Safety of E7070 in Patients With a Solid Tumor as a Single IV Infusion Weekly X 4, Repeated Every 6 Weeks